Literature DB >> 9736545

Influence of assay methodology on the measurement of free serum ceftriaxone concentrations.

S J Kohlhepp1, D N Gilbert, J E Leggett.   

Abstract

The influence of assay methodology on the measurement of the active free fraction of ceftriaxone in plasma was determined. The free fraction was measured by three methods: agar diffusion bioassay, precipitation of plasma protein with methanol followed by high-performance liquid chromatography (HPLC) of the supernatant, and ultrafiltration of plasma followed by HPLC of the filtrate. In human serum, the free ceftriaxone levels were significantly lower (P = 0.03) when measured on ultrafiltrates compared to the other two methods. This difference disappeared when dolphin serum was studied. After ultrafiltration, human serum was shown, by Scatchard plot analysis, to have two ceftriaxone binding sites. Species differences were also demonstrated. Hence, in humans, determination of free plasma ceftriaxone varies with the assay method employed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9736545      PMCID: PMC105804     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  A calculator for finding binding parameters from a Scatchard plot.

Authors:  B E Pennock
Journal:  Anal Biochem       Date:  1973-11       Impact factor: 3.365

2.  Crossover assessment of serum bactericidal activity and pharmacokinetics of five broad-spectrum cephalosporins in the elderly.

Authors:  R G Deeter; M P Weinstein; K A Swanson; J S Gross; L C Bailey
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

3.  Pharmacokinetics of cephalosporin antibiotics: protein-binding considerations.

Authors:  S M Singhvi; A F Heald; E C Schreiber
Journal:  Chemotherapy       Date:  1978       Impact factor: 2.544

4.  Pharmacokinetics and protein binding of ceftriaxone during pregnancy.

Authors:  P Bourget; H Fernandez; V Quinquis; C Delouis
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

5.  Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics.

Authors:  K Stoeckel; P J McNamara; R Brandt; H Plozza-Nottebrock; W H Ziegler
Journal:  Clin Pharmacol Ther       Date:  1981-05       Impact factor: 6.875

6.  Age-associated changes in ceftriaxone pharmacokinetics.

Authors:  W L Hayton; K Stoeckel
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

7.  Plasma protein binding of ceftriaxone.

Authors:  A C Popick; W G Crouthamel; I Bekersky
Journal:  Xenobiotica       Date:  1987-10       Impact factor: 1.908

8.  Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration.

Authors:  K Borner; H Lode; B Hampel; M Pfeuffer; P Koeppe
Journal:  Chemotherapy       Date:  1985       Impact factor: 2.544

9.  Ion pair high-performance liquid chromatographic assay for ceftriaxone.

Authors:  G G Granich; D J Krogstad
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

10.  Use of serum ultrafiltrate in the serum dilution test.

Authors:  J E Leggett; S A Wolz; W A Craig
Journal:  J Infect Dis       Date:  1989-10       Impact factor: 5.226

View more
  1 in total

Review 1.  Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.

Authors:  Antonello Di Paolo; Giovanni Gori; Carlo Tascini; Romano Danesi; Mario Del Tacca
Journal:  Clin Pharmacokinet       Date:  2013-07       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.